Navigation Links
CereScan Supports National Stroke Awareness Month with New Infographic
Date:5/4/2016

CereScan, the nation’s leader in providing statistically measured brain diagnostics, is proud to support the National Stroke Association during National Stroke Awareness Month in May. An infographic created by CereScan will be published on the association’s Facebook and Twitter pages throughout the month. CereScan will donate $1 up to a maximum of $3,000 through users who share the post, with proceeds to benefit the National Stroke Association in their efforts to reduce the incidence of stroke in the United States.    

The graphic, with the intent of promoting and educating through social media, displays common overlapping symptoms of Stroke and Traumatic Brain Injury that too often lead to a misdiagnosis and delayed treatment. Functional imaging, such as SPECT and PET, have been proven effective in identifying key areas of differentiation. An accurate diagnosis starts with better data, and CereScan is committed to helping those suffering the symptoms of stroke (and Traumatic Brain Injury) find the answers they need to live a better life.

“Stroke is the fifth leading cause of death in the United States, and early detection and intervention is critical to a patient’s return to a normal life,” said John Kelley, CEO and Chairman of CereScan. “As new medical technologies are emerging every day, we are also making more effective use of existing technologies to accurately identify serious medical conditions. Functional imaging, specifically through SPECT and PET testing, have been most effective in helping to detect and differentiate stroke from other complex brain conditions.”

Did you know that…

  • Stroke kills almost 130,000 Americans each year? That’s 1 out of every 20 deaths.
  • On average, one American dies from stroke every 4 minutes?
  • Every year, more than 795,000 people in the United States have a stroke?
  • About 87% of all strokes are ischemic strokes, when blood flow to the brain is blocked?
  • Stroke costs the United States an estimated $34 billion each year in healthcare services, medications and missed work?

CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software, PET/CT (Positron Emission Tomography/Computed Tomography) and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:

  • Traumatic Brain Injury
  • Toxic Brain Injury
  • Alzheimer’s Disease
  • Stroke
  • PTSD
  • Other Dementias
  • Mild Cognitive Impairment
  • Parkinson’s Disease
  • Obsessive Compulsive Disorder
  • Bipolar Disorder
  • ADD/ADHD
  • Anxiety Disorder

About CereScan
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13393223.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related biology technology :

1. CereScan CEO John Kelley Featured at Colorado BioScience Association’s BioBoot Camp 2016
2. CereScan Recognized as One of Angel Capital Summit’s Most Promising Companies
3. CereScan Kicks Off Brain Injury Awareness Month with No Cost qEEGs
4. CereScan Named as CO Impact Days and Initiative Finalist
5. CereScan Receives Colorado Advanced Industries Accelerator Grant
6. CereScan Proud to Be Key Sponsor of Wounded Warrior Amputees vs. NFL Stars Flag Football Game
7. CereScan and NFL Alumni Creating A Buzz Around New Brain Imaging Technology During Super Bowl 50
8. CereScan and Molecular Imaging of Colorado Add TRICARE to Approved Insurers
9. CereScan is Coming to Denver Area Theaters
10. CereScan Welcomes Dr. Stuart Stein to Its Scientific and Medical Advisory Board
11. Cryoport Supports Perseus PCI in Melanoma and Ovarian Cancer Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2018)... ... October 02, 2018 , ... ... today announced a new out-of-the-box integration of the Genedata Bioprocess ® ... and laboratory equipment supplier. This enables the automatic import of raw instrument ...
(Date:9/28/2018)... ... 2018 , ... GlycoMark®, Inc. has announced a partnership with ... the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions ... GlycoMark test to its network of physicians through its sales organization and MD ...
(Date:9/27/2018)... , ... September 26, 2018 , ... ... biologics manufacturer, debuted its focus® Pedicle Screw System today at the North American ... 26-29. , The Nvision focus Pedicle Screw System, which received clearance ...
(Date:9/22/2018)... ... September 20, 2018 , ... Catalent Pharma Solutions, the ... and consumer health products, today announced that it will be co-hosting a workshop ... Pharmaceutical Development,”. The one-day event is to be held at the Hilton Boston ...
Breaking Biology Technology:
(Date:10/5/2018)... ... October 04, 2018 , ... EDETEK, the premier provider of ... CDISC U.S. Interchange in Bethesda, MD on October 8-12, 2018. EDETEK is also a ... on November 5-6, 2018. , CDISC Interchanges are global events held annually on ...
(Date:10/3/2018)... ... October 03, 2018 , ... Orbsen ... first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation stromal cell ... progressive diabetic kidney disease in a four-site, pan-European Phase I/II clinical trial. ...
(Date:10/2/2018)... ... October 02, 2018 , ... The Federal Identity ... at Tampa Convention Center. The Palo Alto-based face recognition company, Camvi Technologies Inc., ... 27th. Other speakers included U.S. Federal executives from Department of Defense (DoD) and ...
Breaking Biology News(10 mins):